MERLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 14.986
EU - Europa 8.527
AS - Asia 2.436
SA - Sud America 58
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 13
Totale 26.096
Nazione #
US - Stati Uniti d'America 14.937
IT - Italia 2.707
PL - Polonia 1.656
SE - Svezia 1.421
CN - Cina 992
HK - Hong Kong 873
DE - Germania 629
UA - Ucraina 485
BG - Bulgaria 364
IE - Irlanda 282
FI - Finlandia 264
TR - Turchia 201
GB - Regno Unito 166
CH - Svizzera 139
RU - Federazione Russa 100
FR - Francia 83
IN - India 76
SG - Singapore 73
VN - Vietnam 69
KR - Corea 60
BE - Belgio 52
CA - Canada 45
AT - Austria 34
RO - Romania 33
BR - Brasile 28
JP - Giappone 27
NL - Olanda 27
ES - Italia 26
EU - Europa 25
SN - Senegal 23
IR - Iran 17
CL - Cile 13
AU - Australia 11
GR - Grecia 9
EG - Egitto 8
PH - Filippine 8
CO - Colombia 7
DK - Danimarca 6
HR - Croazia 6
MY - Malesia 6
ID - Indonesia 5
TG - Togo 5
CZ - Repubblica Ceca 4
NO - Norvegia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BD - Bangladesh 3
EE - Estonia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
MX - Messico 3
PE - Perù 3
PK - Pakistan 3
RS - Serbia 3
TH - Thailandia 3
AL - Albania 2
AO - Angola 2
EC - Ecuador 2
HU - Ungheria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SM - San Marino 2
UG - Uganda 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SO - Somalia 1
Totale 26.096
Città #
Fairfield 2.068
Chandler 1.782
Warsaw 1.650
Woodbridge 1.499
Ashburn 1.309
Ann Arbor 1.108
Houston 1.046
Seattle 876
Hong Kong 868
Wilmington 851
Cambridge 716
Trieste 551
Jacksonville 540
Princeton 454
Sofia 363
Beijing 342
Dublin 273
Izmir 186
Boardman 175
Dearborn 162
Milan 139
Rome 121
San Diego 118
Helsinki 116
Bern 109
Grafing 103
Bremen 67
Dong Ket 66
Washington 57
Redwood City 53
Seoul 53
Venezia 52
Brussels 50
Des Moines 47
Falls Church 46
Naples 46
Udine 46
Jinan 43
London 39
Pune 39
Turin 37
Nanjing 35
Norwalk 35
Mestre 34
Redmond 33
Shanghai 32
Vienna 31
Chicago 29
Kunming 28
Guangzhou 27
Hefei 25
Venice 24
Dakar 23
Toronto 21
São Paulo 20
Bologna 19
Florence 18
Lappeenranta 18
Fremont 17
Napoli 17
Tokyo 17
Verona 17
Bari 16
Padova 16
Buffalo 15
Karlsruhe 15
Timisoara 15
Cagliari 14
Council Bluffs 14
Nanchang 14
Phoenix 14
San Francisco 14
Shenyang 14
Treviso 14
Boydton 13
Palermo 13
Paris 13
Leawood 12
New York 12
San Mateo 12
Taiyuan 12
Dongguan 11
Hangzhou 11
Augusta 10
Buja 10
Changsha 10
Düsseldorf 10
Ancona 9
Brescia 9
Catania 9
Hebei 9
Perugia 9
Pescopagano 9
Pisa 9
Tappahannock 9
Zhengzhou 9
Gorizia 8
Haikou 8
Mumbai 8
Tianjin 8
Totale 19.223
Nome #
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 345
Role of Titin Missense Variants in Dilated Cardiomyopathy 335
Natural History of Dilated Cardiomyopathy in Children 333
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 332
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 296
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 285
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives 283
null 266
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 261
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 234
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. 221
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 218
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 215
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 214
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects 211
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 205
Treatment of Functional Mitral Regurgitation in Heart Failure 202
Com'è cambiata la storia naturale della cardiomiopatia dilatativa? 197
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 196
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 190
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 184
Arresto cardiaco extraospedaliero: le competenze degli studenti dell’Università degli Studi di Trieste sulle manovre rianimatorie e l’utilizzo del defibrillatore automatico esterno 184
Influence of Aging on Short- and Long-term Heart Rate Variability in Patients with Heart Failure 182
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 182
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. 180
Historical Terminology, Classifications, and Present Definition of DCM. 179
Predictors for Restoration of Normal Left Ventricular Function in Response to Cardiac Resynchronization Therapy Measured at Time of Implantation. 178
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 177
Dieci quesiti in tema di miocardite eosinofila [Ten questions about eosinophilic myocarditis] 177
Emergency Surgery and Cardiac Devices 175
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 175
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 175
Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy. 174
DEFINITION, CLASSIFICATION, EPIDEMIOLOGY, AND CLINICAL RELEVANCE OF CARDIOMYOPATHIES. 172
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 171
Evolving concepts in dilated cardiomyopathy 171
HRV analysis in CHF patients with different etiologies by means of spectral and nonlinear indexes 167
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 167
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 165
Formation of the inflammasome in acute myocarditis. 165
Genetics of Dilated Cardiomyopathy: Clinical Implications 164
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together 162
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 161
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 161
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 160
Hypertrophic cardiomyopathy: Clinical assessment and differential diagnosis 159
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 158
Chapter 12: Prognostic Stratification and Importance of Follow-Up 158
Apoptosis in patients with acute myocarditis. 157
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. 156
Prognostic role of hemodynamic evaluation at rest and at maximum workload in patients with idiopathic dilated cardiomyopathy. 156
The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance. 155
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. 154
null 153
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 152
Documento di consenso Società Italiana di Cardiologia- Società Italiana di Nefrologia: Ruolo dell’asse cardio-renale nella prevenzione e trattamento delle patologie cardiovascolari – Parte II: Dalle strategie di prevenzione al trattamento del paziente con coinvolgimento cardio-renale 151
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis 151
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy 151
Cardiovascular aging: the unveiled enigma from bench to bedside 149
Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function 149
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 147
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 146
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 145
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 144
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 141
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 141
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 140
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 139
Chapter 14: Unresolved Issues and Future Perspectives 139
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 138
Dilated Cardiomyopathy. From Genetics to Clinical Management 137
Chapter 3: Pathophysiology 136
Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. 134
Cardiac amyloidosis: a changing epidemiology with open challenges 132
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 132
null 131
Myocarditis in Clinical Practice 129
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 129
Truncations of titin causing dilated cardiomyopathy 128
null 128
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 128
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 127
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 127
Pulmonary artery aneurysm and sarcoidosis 126
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 124
Prognostic impact of familial screening in dilated cardiomyopathy. 123
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 123
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 123
Clinical management of dilated cardiomyopathy: Current knowledge and future perspectives 123
Characterization and Long-Term Prognosis of Postmyocarditic Dilated Cardiomyopathy Compared With Idiopathic Dilated Cardiomyopathy 122
null 121
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 121
The (ultra) sound of a burning heart: A matter of speckles 121
Gender medicine in dilated cardiomyopathy: pride and prejudice 121
Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. 120
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. 120
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 119
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 118
null 117
Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias 117
Totale 16.833
Categoria #
all - tutte 74.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.312 0 0 0 0 0 0 0 0 0 240 673 399
2019/20205.063 220 226 282 799 338 543 552 494 617 368 350 274
2020/20214.697 332 378 388 749 522 474 346 328 209 423 183 365
2021/20223.225 127 224 219 250 180 306 153 92 376 335 230 733
2022/20235.515 421 701 543 839 459 867 82 464 585 120 276 158
2023/20243.880 360 263 224 363 432 521 765 712 123 117 0 0
Totale 27.398